INFORMED.
LIVE

Onesource Specialty Pharma Limited

BSE: ONESOURCE544292ISIN INE013P01021
  • Healthcare
  • Pharmaceuticals
  • BSE 500

Share price

₹1,595.45+16.20 (+1.03%)
as of 18 Sep 2026
Onesource Specialty Pharma Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹1,862.80 to ₹1,595.45 (-14.4%). Low ₹1,149.35, high ₹1,887.30. Volume shown below the price.
52W high
₹1,924.00
52W low
₹1,075.00
Off 52W high
-17.08%
1M return
+4.92%
3M return
-0.74%
6M return
+9.09%
1Y return
-14.35%
20D avg volume
57,219
50 DMA
₹1,588.13
200 DMA
₹1,581.37

Key ratios Consolidated

Market cap
₹18,295 Cr
Current price
₹1,595.45
52W high / low
₹1,924.00 / ₹1,075.00
Face value
₹1.00
P/E
-376.21
P/B
EPS (TTM)
₹-4.24
Book value / share
ROE
ROCE
0.40%
Operating margin
Net margin
Debt / equity
0.22
Net debt
₹1,241 Cr
Interest cover
0.25
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
193.7 days

About

In plain English

OneSource Specialty Pharma is a contract manufacturer that helps other drug companies make complex medicines, especially the kind that are injected or combine a drug with a device like an auto-injector pen. For example, they make the pens used for weight-loss and diabetes drugs like semaglutide (the active ingredient in Ozempic and Wegovy), and they also produce sterile injectable vials and soft gelatin capsules (like liquid-filled pills). Their customers are big pharmaceutical companies, including a top-3 animal health company and a top-10 US generics player, who hire OneSource to develop and manufacture these products because they have specialized facilities and regulatory approvals. They make money by charging these clients fees for development and manufacturing services.

AI-generated summary, written from the company's own filings and disclosures. Every figure elsewhere on this page comes from exchange data, not from a model. See our editorial standards. Generated 24 Jul 2026.

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q4 FY24
Income statement
449.02428.22290.34375.76327.27425.95392.5667.98
3.802.094.623.045.272.895.390.58
428.23430.63380.89373.06334.07345.34363.94107.64
141.19144.5187.72123.5583.3690.9992.8612.31
0.000.000.000.000.007.95
68.6862.7464.1962.8258.4451.0657.3522.78
30.8122.5138.2333.9627.4833.4145.8220.73
71.7571.8369.6469.8367.8068.4968.7719.06
114.68127.29114.4692.9687.4381.4732.77
24.59-0.33-85.925.74-1.5383.5034.02-39.08
-4.300.03-7.090.00-2.870.00-100.520.00
20.29-0.29-93.015.74-4.4083.50-66.50-39.08
-4.704.89-4.31-4.74-4.21-15.392.350.00
25.004.60-88.7010.48-0.1998.20-68.85-39.08
2.180.40-7.740.92-0.028.61-6.31-9.41
Key metrics
122.8594.0514.86109.5390.88185.4048.090.71
27.40%22.00%5.10%29.10%27.80%43.50%12.30%1.00%
5.60%1.10%-30.60%2.80%-0.10%23.10%-17.50%-57.50%
0.30%0.60%1.80%
37.20%0.50%-26.00%452.80%
13,257.90%-95.30%-28.80%126.80%
MetricTTMFY26FY25FY24
Income statement
1,5431,4221,445
13.5515.0217.47
1,6131,5191,419
496.97436.75328.24
0.000.0030.10
258.43242.25215.26
125.51122.19166.32
283.05279.09273.88
449.39430.47328.05
-55.92-82.0343.78
-11.36-9.93-110.84
-67.27-91.96-67.07
-8.86-18.16-49.78
-48.62-73.80-17.97
-4.24-6.44-1.63
Key metrics
341.29309.32373.13
22.11%21.80%25.80%
-3.15%-5.20%-1.20%
0.40%1.50%
-1.60%
-310.70%
-560.55-21.52
-0.121.20
0.220.13
1,241615.11
193.7100.8
Balance sheet
8,2107,550
1,4261,086
35.68156.48
690.22416.60
438.96158.06
177.27170.41
925.86897.35
374.55175.51
1,4421,114
1,276771.59
712.59552.26
563.70219.33
5,8315,881
Cash flow
8.52-21.52
-494.98-201.08
359.441,987
569.070.00
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q4 FY24
Income statement
446.47418.96290.22375.19321.01477.41336.7567.98
3.792.094.623.045.253.915.010.58
399.03401.25349.94341.12301.45306.45314.26107.63
141.19145.4387.24123.4387.5594.6087.3512.31
0.000.000.000.000.00-8.90
68.3961.6564.0662.5358.1550.9457.1922.78
30.5222.2537.9833.3127.0332.3943.9220.71
36.1834.7434.5734.2133.2833.5933.9819.06
121.63135.42119.4597.7190.5077.2332.77
51.2319.81-55.0937.1024.82174.8827.50-39.07
0.001.67-7.090.000.000.00-100.52-0.95
51.2321.48-62.1937.1024.82174.88-73.02-40.02
0.000.000.000.000.000.00
51.2321.48-62.1937.1024.82174.19-73.02-40.02
4.471.87-5.433.242.1715.28-6.69-9.63
Key metrics
117.9378.4710.36104.6285.13240.864.88-0.25
26.40%18.70%3.60%27.90%26.50%50.50%1.40%-0.40%
11.50%5.10%-21.40%9.90%7.70%36.50%-21.70%-58.90%
0.60%1.10%3.30%
39.10%-12.20%-13.80%451.90%
106.40%-87.70%14.80%192.70%
MetricTTMFY26FY25FY24
Income statement
1,5311,4051,300
13.5415.0117.68
1,4911,3941,226
497.29441.26330.17
0.000.002.61
256.63240.45214.80
124.06120.58161.65
139.70136.79134.51
474.21451.41307.33
53.0526.6390.80
-5.42-5.42-112.25
47.6221.21-21.45
0.000.0041.45
47.6221.2119.31
4.151.851.81
Key metrics
311.38278.58274.71
20.34%19.80%21.10%
3.11%1.50%1.50%
2.10%2.20%
8.10%
9.80%
-420.80-46.59
2.60-2.41
0.210.13
1,248688.39
200.6122.2
Balance sheet
8,2767,390
1,4571,024
28.0683.20
735.25441.97
438.96153.44
170.96164.68
925.86897.35
401.94160.06
1,5241,069
1,276771.59
712.59552.26
563.70219.33
5,9505,920
Cash flow
55.17-46.59
-477.60145.78
361.061,982
475.970.00

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
+27.24%
Profit YoY (TTM)
-44.61%

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
+27.15%
Profit YoY (TTM)
-390.12%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
30.49%
HolderTypeHoldingPreviousChange
TENSHI PHARMACEUTICALS PRIVATE LIMITEDPromoter18.40%
MOTILAL OSWAL MUTUAL FUNDPublic7.06%
KARUNA BUSINESS SOLUTIONS LLPPromoter7.06%
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDPublic4.96%
PRONOMZ VENTURES LLPPromoter Group2.41%
ROUTE ONE OFFSHORE MASTER FUND L.P.Public2.32%
ROUTE ONE FUND I, L.P.Public2.07%
SBI LIFE INSURANCE CO. LTDPublic2.06%
AMANSA HOLDINGS PRIVATE LIMITEDPublic1.86%
THINK INVESTMENTS PCCPublic1.79%
FIDELITY SECURITIES FUND: FIDELITY BLUE CHIP GROWTH FUNDPublic1.76%
360 ONE SPECIAL OPPORTUNITIES FUND - SERIES 12Public1.62%
ARCO LAB PRIVATE LIMITEDPromoter Group1.60%
AXIS MUTUAL FUNDPublic1.33%
TIMF HOLDINGSPublic1.26%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results

Coverage